-
Increased COVID-19 testing triggers demand for kit reagents
Shem Oirere
February 22, 2022
The emerging new mutations of COVID-19 is fueling the global drive for mass testing hence increasing demand for reagents for both testing kits and vaccine production especially in low- and middle-income countries.
-
Pharma Sources Insight December 2021: From the Editor
Pharma Sources Insight
December 28, 2021
Has COVID been Injecting Cash into Pharma? How is Quantum going to impact pharma?
-
Demand for High-End COVID-19 Vaccines to Drive Growth of Excipients Market
SHEM OIRERE
December 17, 2021
The COVID-19 pandemic has infected 247 million people and killed five million others as of November 01, 2021 the situation still looks grim due to the high infection rates, the prolonged SARS-CoV-2 virus...
-
Progress of Research on Key COVID-19 Treatments
Deborah Seah
December 17, 2021
At the point of writing the COVID-19 pandemic is nearing its two-year run with more than four million deaths and a total of 219 million cases worldwide. Scientists across the world are still scrambling to better understand...
-
Where Are the Oral COVID-19 Vaccines Stand Now?
Lin Zhang
December 17, 2021
The novel coronavirus, SARS-CoV-2, has led to an unprecedented international health crisis and is continuing its spread across the world, with more than 218 million confirmed cases of COVID-19, including more than 4.5 million deaths, reported to the WHO a
-
A Look at 2021 Mergers and Acquisitions
SHEM OIRERE
December 17, 2021
The COVID-19 health crisis has introduced new dynamics in the global healthcare system while pushing leading pharmaceutical companies into investing more in research and development as others are enticed into mergers...
-
Syringe Shortages Threatens to Disrupt COVID-19 Vaccination in Africa
SHEM OIRERE
November 08, 2021
The current acute shortage of syringes for administering COVID-19 vaccine in Africa and other emerging nations, is yet another indication of how disruptive the SAR-CoV-2 virus driven disease has been on the global supply chain.
-
Small Molecule and Great Potential: Oral Small Molecule COVID-19 Pharmaceutical Chemicals
PharmaSources/Xiaoyaowan
October 28, 2021
Recently, MSD announced to initiate the Phase III clinical trial of its oral small molecule COVID-19 drug - Molnupiravir (MK-4482).
-
New Progress of Key Chinese COVID-19 Drugs under Research
PharmaSources/Xiaoyaowan
October 28, 2021
With the wide spread of Delta mutant worldwide, the COVID-19 infection situation is worrisome. In addition to vaccination for prevention, drug therapy can alleviate the disease deterioration...
-
How Africa vaccine production would boost global adjuvants market
SHEM OIRERE
September 15, 2021
The drive to expand vaccine manufacturing in Africa is gaining momentum with several new partnership agreements including technology transfer for the production of both malaria and COVID-19 vaccine...